{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T21:59:45Z","timestamp":1779400785481,"version":"3.53.1"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T00:00:00Z","timestamp":1732579200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T00:00:00Z","timestamp":1732579200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100022077","name":"INRAe","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100022077","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004901","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de Minas Gerais","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004901","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Probiotics & Antimicro. Prot."],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s12602-024-10414-0","type":"journal-article","created":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T07:25:07Z","timestamp":1732605907000},"page":"4675-4689","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Postbiotic Effect of Escherichia coli CEC15 and Escherichia coli Nissle 1917 on a Murine Model of 5-FU-induced Intestinal Mucositis"],"prefix":"10.1007","volume":"17","author":[{"given":"Rafael","family":"de Assis Gl\u00f3ria","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tales Fernando","family":"da Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom\u00e1s Andrade Magalh\u00e3es","family":"Gomes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K\u00e1tia Duarte","family":"Vital","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone Od\u00edlia Antunes","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valbert Nascimento","family":"Cardoso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00canio","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Mark","family":"Chatel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Langella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Cherbuy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yves","family":"Le Loir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gw\u00e9na\u00ebl","family":"Jan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c9ric","family":"Gu\u00e9don","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasco Ariston de Carvalho","family":"Azevedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,26]]},"reference":[{"key":"10414_CR1","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1038\/nrgastro.2014.66","volume":"11","author":"C Hill","year":"2014","unstructured":"Hill C, Guarner F, Reid G et al (2014) The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol 11:506\u2013514. https:\/\/doi.org\/10.1038\/nrgastro.2014.66","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10414_CR2","doi-asserted-by":"publisher","first-page":"a010074","DOI":"10.1101\/cshperspect.a010074","volume":"3","author":"J Behnsen","year":"2013","unstructured":"Behnsen J, Deriu E, Sassone-Corsi M, Raffatellu M (2013) Probiotics: properties, examples, and specific applications. Cold Spring Harb Perspect Med 3:a010074\u2013a010074. https:\/\/doi.org\/10.1101\/cshperspect.a010074","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10414_CR3","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1038\/nature20557","volume":"540","author":"M Sassone-Corsi","year":"2016","unstructured":"Sassone-Corsi M, Nuccio S-P, Liu H et al (2016) Microcins mediate competition among Enterobacteriaceae in the inflamed gut. Nature 540:280\u2013283. https:\/\/doi.org\/10.1038\/nature20557","journal-title":"Nature"},{"key":"10414_CR4","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1111\/j.1365-2982.2008.01258.x","volume":"21","author":"F B\u00e4r","year":"2009","unstructured":"B\u00e4r F, Von Koschitzky H, Roblick U et al (2009) Cell-free supernatants of Escherichia coli Nissle 1917 modulate human colonic motility: evidence from an in vitro organ bath study. Neurogastroenterology Motil 21:559\u2013e17. https:\/\/doi.org\/10.1111\/j.1365-2982.2008.01258.x","journal-title":"Neurogastroenterology Motil"},{"key":"10414_CR5","doi-asserted-by":"publisher","first-page":"2876","DOI":"10.1128\/IAI.00059-09","volume":"77","author":"MP Leatham","year":"2009","unstructured":"Leatham MP, Banerjee S, Autieri SM et al (2009) Precolonized Human Commensal Escherichia coli strains serve as a barrier to E. Coli O157:H7 growth in the streptomycin-treated mouse intestine. Infect Immun 77:2876\u20132886. https:\/\/doi.org\/10.1128\/IAI.00059-09","journal-title":"Infect Immun"},{"key":"10414_CR6","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1111\/j.1574-6968.2008.01405.x","volume":"290","author":"R Reissbrodt","year":"2009","unstructured":"Reissbrodt R, Hammes WP, dal Bello F et al (2009) Inhibition of growth of Shiga toxin-producing Escherichia coli by nonpathogenic Escherichia coli. FEMS Microbiol Lett 290:62\u201369. https:\/\/doi.org\/10.1111\/j.1574-6968.2008.01405.x","journal-title":"FEMS Microbiol Lett"},{"key":"10414_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijmm.2012.11.006","volume":"303","author":"SA Rund","year":"2013","unstructured":"Rund SA, Rohde H, Sonnenborn U, Oelschlaeger TA (2013) Antagonistic effects of probiotic Escherichia coli Nissle 1917 on EHEC strains of serotype O104:H4 and O157:H7. Int J Med Microbiol 303:1\u20138. https:\/\/doi.org\/10.1016\/j.ijmm.2012.11.006","journal-title":"Int J Med Microbiol"},{"key":"10414_CR8","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1007\/s40200-020-00511-6","volume":"19","author":"A Behrouzi","year":"2020","unstructured":"Behrouzi A, Mazaheri H, Falsafi S et al (2020) Intestinal effect of the probiotic Escherichia coli strain Nissle 1917 and its OMV. J Diabetes Metab Disord 19:597\u2013604. https:\/\/doi.org\/10.1007\/s40200-020-00511-6","journal-title":"J Diabetes Metab Disord"},{"key":"10414_CR9","doi-asserted-by":"publisher","first-page":"283","DOI":"10.3920\/BM2020.0094","volume":"12","author":"CJ Chiang","year":"2021","unstructured":"Chiang CJ, Chao YP, Ali A et al (2021) Probiotic Escherichia coli Nissle inhibits IL-6 and MAPK-mediated cardiac hypertrophy during STZ-induced diabetes in rats. Benef Microbes 12:283\u2013293. https:\/\/doi.org\/10.3920\/BM2020.0094","journal-title":"Benef Microbes"},{"key":"10414_CR10","first-page":"201","volume":"47","author":"AH Faghihi","year":"2015","unstructured":"Faghihi AH, Agah S, Masoudi M et al (2015) Efficacy of Probiotic Escherichia coli Nissle 1917 in patients with irritable bowel syndrome: a double blind placebo-controlled Randomized Trial. Acta Med Indones 47:201\u2013208","journal-title":"Acta Med Indones"},{"key":"10414_CR11","doi-asserted-by":"publisher","first-page":"4020","DOI":"10.1111\/jam.15541","volume":"132","author":"PJ Hare","year":"2022","unstructured":"Hare PJ, Englander HE, Mok WWK (2022) Probiotic Escherichia coli Nissle 1917 inhibits bacterial persisters that survive fluoroquinolone treatment. J Appl Microbiol 132:4020\u20134032. https:\/\/doi.org\/10.1111\/jam.15541","journal-title":"J Appl Microbiol"},{"key":"10414_CR12","doi-asserted-by":"publisher","unstructured":"Olbertz D, Proquitt\u00e9 H, Patzer L et al (2022) Potential benefit of probiotic E. coli Nissle in term neonates. Klin Padiatr. https:\/\/doi.org\/10.1055\/a-1970-4340","DOI":"10.1055\/a-1970-4340"},{"key":"10414_CR13","doi-asserted-by":"publisher","unstructured":"Pradhan S, Weiss AA (2020) Probiotic properties of Escherichia coli Nissle in human intestinal organoids. mBio 11. https:\/\/doi.org\/10.1128\/mBio.01470-20","DOI":"10.1128\/mBio.01470-20"},{"key":"10414_CR14","doi-asserted-by":"publisher","first-page":"819336","DOI":"10.3389\/fmicb.2022.819336","volume":"13","author":"G Teng","year":"2022","unstructured":"Teng G, Liu Z, Liu Y et al (2022) Probiotic Escherichia coli Nissle 1917 expressing Elafin protects against inflammation and restores the gut microbiota. Front Microbiol 13:819336","journal-title":"Front Microbiol"},{"key":"10414_CR15","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1111\/j.1574-6968.2007.00889.x","volume":"275","author":"S Homburg","year":"2007","unstructured":"Homburg S, Oswald E, Hacker J, Dobrindt U (2007) Expression analysis of the colibactin gene cluster coding for a novel polyketide in Escherichia coli. FEMS Microbiol Lett 275:255\u2013262. https:\/\/doi.org\/10.1111\/j.1574-6968.2007.00889.x","journal-title":"FEMS Microbiol Lett"},{"key":"10414_CR16","doi-asserted-by":"publisher","first-page":"501","DOI":"10.4161\/gmic.21737","volume":"3","author":"M Olier","year":"2012","unstructured":"Olier M, Marcq I, Salvador-Cartier C et al (2012) Genotoxicity of Escherichia coli Nissle 1917 strain cannot be dissociated from its probiotic activity. Gut Microbes 3:501\u2013509. https:\/\/doi.org\/10.4161\/gmic.21737","journal-title":"Gut Microbes"},{"key":"10414_CR17","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1556\/EuJMI.3.2013.2.6","volume":"3","author":"S Bereswill","year":"2013","unstructured":"Bereswill S, Fischer A, Dunay IR et al (2013) Pro-inflammatory potential of Escherichia coli strains K12 and nissle 1917 in a murine model of acute ileitis. Eur J Microbiol Immunol (Bp) 3:126\u2013134. https:\/\/doi.org\/10.1556\/EuJMI.3.2013.2.6","journal-title":"Eur J Microbiol Immunol (Bp)"},{"key":"10414_CR18","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/ismej.2014.111","volume":"9","author":"J Tomas","year":"2015","unstructured":"Tomas J, Reygner J, Mayeur C et al (2015) Early colonizing Esche richia coli elicits remodeling of rat colonic epithelium shifting toward a new homeostatic state. ISME J 9:46\u201358. https:\/\/doi.org\/10.1038\/ismej.2014.111","journal-title":"ISME J"},{"key":"10414_CR19","doi-asserted-by":"publisher","first-page":"11431","DOI":"10.1038\/s41598-019-47611-9","volume":"9","author":"U Escribano-Vazquez","year":"2019","unstructured":"Escribano-Vazquez U, Verstraeten S, Martin R et al (2019) The commensal Escherichia coli CEC15 reinforces intestinal defences in gnotobiotic mice and is protective in a chronic colitis mouse model. Sci Rep 9:11431. https:\/\/doi.org\/10.1038\/s41598-019-47611-9","journal-title":"Sci Rep"},{"key":"10414_CR20","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1186\/s12866-023-03112-4","volume":"23","author":"TF da Silva","year":"2023","unstructured":"da Silva TF, Gl\u00f3ria R, de Sousa A et al (2023) Comprehensive probiogenomics analysis of the commensal Escherichia coli CEC15 as a potential probiotic strain. BMC Microbiol 23:364. https:\/\/doi.org\/10.1186\/s12866-023-03112-4","journal-title":"BMC Microbiol"},{"key":"10414_CR21","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1007\/s12602-022-09978-6","volume":"15","author":"ND Coelho-Rocha","year":"2023","unstructured":"Coelho-Rocha ND, de Jesus LCL, Barroso FAL et al (2023) Evaluation of Probiotic properties of Novel Brazilian lactiplantibacillus plantarum strains. Probiotics Antimicrob Proteins 15:160\u2013174. https:\/\/doi.org\/10.1007\/s12602-022-09978-6","journal-title":"Probiotics Antimicrob Proteins"},{"key":"10414_CR22","doi-asserted-by":"publisher","first-page":"109502","DOI":"10.1016\/j.foodres.2020.109502","volume":"136","author":"PF Cuevas-Gonz\u00e1lez","year":"2020","unstructured":"Cuevas-Gonz\u00e1lez PF, Liceaga AM, Aguilar-Toal\u00e1 JE (2020) Postbiotics and paraprobiotics: from concepts to applications. Food Res Int 136:109502. https:\/\/doi.org\/10.1016\/j.foodres.2020.109502","journal-title":"Food Res Int"},{"key":"10414_CR23","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.tifs.2018.03.009","volume":"75","author":"JE Aguilar-Toal\u00e1","year":"2018","unstructured":"Aguilar-Toal\u00e1 JE, Garcia-Varela R, Garcia HS et al (2018) Postbiotics: an evolving term within the functional foods field. Trends Food Sci Technol 75:105\u2013114. https:\/\/doi.org\/10.1016\/j.tifs.2018.03.009","journal-title":"Trends Food Sci Technol"},{"key":"10414_CR24","doi-asserted-by":"publisher","first-page":"544490","DOI":"10.3389\/fmicb.2020.544490","volume":"11","author":"VL Batista","year":"2020","unstructured":"Batista VL, da Silva TF, de Jesus LCL et al (2020) Probiotics, Prebiotics, Synbiotics, and Paraprobiotics as a Therapeutic Alternative for Intestinal Mucositis. Front Microbiol 11:544490. https:\/\/doi.org\/10.3389\/fmicb.2020.544490","journal-title":"Front Microbiol"},{"key":"10414_CR25","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1038\/s41575-021-00440-6","volume":"18","author":"S Salminen","year":"2021","unstructured":"Salminen S, Collado MC, Endo A et al (2021) The International Scientific Association of Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of postbiotics. Nat Rev Gastroenterol Hepatol 18:649\u2013667. https:\/\/doi.org\/10.1038\/s41575-021-00440-6","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10414_CR26","doi-asserted-by":"publisher","first-page":"291","DOI":"10.3390\/nu15020291","volume":"15","author":"L Ma","year":"2023","unstructured":"Ma L, Tu H, Chen T (2023) Postbiotics in human health: a narrative review. Nutrients 15:291. https:\/\/doi.org\/10.3390\/nu15020291","journal-title":"Nutrients"},{"key":"10414_CR27","doi-asserted-by":"publisher","first-page":"9938","DOI":"10.1038\/s41598-019-46076-0","volume":"9","author":"WI Izuddin","year":"2019","unstructured":"Izuddin WI, Loh TC, Foo HL et al (2019) Postbiotic L. Plantarum RG14 improves ruminal epithelium growth, immune status and upregulates the intestinal barrier function in post-weaning lambs. Sci Rep 9:9938. https:\/\/doi.org\/10.1038\/s41598-019-46076-0","journal-title":"Sci Rep"},{"key":"10414_CR28","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/1471-2172-11-15","volume":"11","author":"GS Jensen","year":"2010","unstructured":"Jensen GS, Benson KF, Carter SG, Endres JR (2010) GanedenBC30\u2122 cell wall and metabolites: anti-inflammatory and immune modulating effects in vitro. BMC Immunol 11:15. https:\/\/doi.org\/10.1186\/1471-2172-11-15","journal-title":"BMC Immunol"},{"key":"10414_CR29","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.clnu.2015.12.004","volume":"36","author":"R Nocerino","year":"2017","unstructured":"Nocerino R, Paparo L, Terrin G et al (2017) Cow\u2019s milk and rice fermented with Lactobacillus paracasei CBA L74 prevent infectious diseases in children: a randomized controlled trial. Clin Nutr 36:118\u2013125. https:\/\/doi.org\/10.1016\/j.clnu.2015.12.004","journal-title":"Clin Nutr"},{"key":"10414_CR30","doi-asserted-by":"publisher","first-page":"3560","DOI":"10.3390\/nu12113560","volume":"12","author":"Y Vandenplas","year":"2020","unstructured":"Vandenplas Y, de Halleux V, Arciszewska M et al (2020) A partly fermented infant formula with postbiotics Including 3\u2032-GL, specific oligosaccharides, 2\u2032-FL, and milk Fat supports adequate growth, is safe and well-tolerated in healthy term infants: a double-blind, randomised, controlled. Multi-country Trial. Nutrients 12:3560. https:\/\/doi.org\/10.3390\/nu12113560","journal-title":"Multi-country Trial. Nutrients"},{"key":"10414_CR31","doi-asserted-by":"publisher","first-page":"2519","DOI":"10.1093\/jn\/126.10.2519","volume":"126","author":"GS Howarth","year":"1996","unstructured":"Howarth GS, Francis GL, Cool JC et al (1996) Milk growth factors enriched from cheese whey ameliorate intestinal damage by Methotrexate when administered orally to rats. J Nutr 126:2519\u20132530. https:\/\/doi.org\/10.1093\/jn\/126.10.2519","journal-title":"J Nutr"},{"key":"10414_CR32","first-page":"1830","volume":"9","author":"LM Mustachio","year":"2019","unstructured":"Mustachio LM, Roszik J, Farria AT et al (2019) Repression of GCN5 expression or activity attenuates c-MYC expression in non-small cell lung cancer. Am J Cancer Res 9:1830\u20131845","journal-title":"Am J Cancer Res"},{"key":"10414_CR33","doi-asserted-by":"publisher","first-page":"e0156289","DOI":"10.1371\/journal.pone.0156289","volume":"11","author":"N Eissa","year":"2016","unstructured":"Eissa N, Hussein H, Wang H et al (2016) Stability of reference genes for Messenger RNA quantification by real-time PCR in mouse Dextran Sodium Sulfate Experimental Colitis. PLoS ONE 11:e0156289. https:\/\/doi.org\/10.1371\/journal.pone.0156289","journal-title":"PLoS ONE"},{"key":"10414_CR34","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v23.i7.1180","volume":"23","author":"L Zheng","year":"2017","unstructured":"Zheng L, Zhang Y-L, Dai Y-C et al (2017) Jianpi Qingchang decoction alleviates ulcerative colitis by inhibiting nuclear factor-\u03baB activation. World J Gastroenterol 23:1180. https:\/\/doi.org\/10.3748\/wjg.v23.i7.1180","journal-title":"World J Gastroenterol"},{"key":"10414_CR35","doi-asserted-by":"publisher","unstructured":"Stifter SA, Bhattacharyya N, Pillay R et al (2016) Functional interplay between type I and II interferons is essential to limit Influenza A virus-induced tissue inflammation. PLoS Pathog 12. https:\/\/doi.org\/10.1371\/journal.ppat.1005378","DOI":"10.1371\/journal.ppat.1005378"},{"key":"10414_CR36","doi-asserted-by":"publisher","unstructured":"Zhu J, Yang F, Sang L et al (2015) IL-33 Aggravates DSS-Induced Acute Colitis in Mouse Colon Lamina Propria by Enhancing Th2 Cell Responses. Mediators Inflamm 2015:1\u201312. https:\/\/doi.org\/10.1155\/2015\/913041","DOI":"10.1155\/2015\/913041"},{"key":"10414_CR37","doi-asserted-by":"publisher","first-page":"e1208468","DOI":"10.1080\/21688370.2016.1208468","volume":"4","author":"V Volynets","year":"2016","unstructured":"Volynets V, Rings A, B\u00e1rdos G et al (2016) Intestinal barrier analysis by assessment of mucins, tight junctions, and \u03b1-defensins in healthy C57BL\/6J and BALB\/cJ mice. Tissue Barriers 4:e1208468. https:\/\/doi.org\/10.1080\/21688370.2016.1208468","journal-title":"Tissue Barriers"},{"key":"10414_CR38","doi-asserted-by":"publisher","first-page":"107","DOI":"10.3390\/microorganisms9010107","volume":"9","author":"FAL Barroso","year":"2021","unstructured":"Barroso FAL, de Jesus LCL, de Castro CP et al (2021) Intake of Lactobacillus delbrueckii (pExu:hsp65) prevents the inflammation and the disorganization of the intestinal mucosa in a mouse model of Mucositis. Microorganisms 9:107. https:\/\/doi.org\/10.3390\/microorganisms9010107","journal-title":"Microorganisms"},{"key":"10414_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2019\/6740616","volume":"2019","author":"H-C Tsai","year":"2019","unstructured":"Tsai H-C, Chang F-P, Li T-H et al (2019) Elafibranor inhibits chronic kidney Disease Progression in NASH mice. Biomed Res Int 2019:1\u201314. https:\/\/doi.org\/10.1155\/2019\/6740616","journal-title":"Biomed Res Int"},{"key":"10414_CR40","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1007\/s10620-015-3935-y","volume":"61","author":"V Volynets","year":"2016","unstructured":"Volynets V, Reichold A, B\u00e1rdos G et al (2016) Assessment of the intestinal barrier with five different permeability tests in healthy C57BL\/6J and BALB\/cJ mice. Dig Dis Sci 61:737\u2013746. https:\/\/doi.org\/10.1007\/s10620-015-3935-y","journal-title":"Dig Dis Sci"},{"key":"10414_CR41","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.3390\/microorganisms10071418","volume":"10","author":"VL Batista","year":"2022","unstructured":"Batista VL, De Jesus LCL, Tavares LM et al (2022) Paraprobiotics and postbiotics of Lactobacillus delbrueckii CIDCA 133 mitigate 5-FU-Induced intestinal inflammation. Microorganisms 10:1418. https:\/\/doi.org\/10.3390\/microorganisms10071418","journal-title":"Microorganisms"},{"key":"10414_CR42","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1007\/s12602-021-09842-z","volume":"15","author":"LM Trindade","year":"2023","unstructured":"Trindade LM, Torres L, Matos ID et al (2023) Paraprobiotic lacticaseibacillus rhamnosus protects intestinal damage in an experimental murine model of Mucositis. Probiotics Antimicrob Proteins 15:338\u2013350. https:\/\/doi.org\/10.1007\/s12602-021-09842-z","journal-title":"Probiotics Antimicrob Proteins"},{"key":"10414_CR43","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1080\/01635581.2017.1263747","volume":"69","author":"H Wang","year":"2017","unstructured":"Wang H, Jatmiko YD, Bastian SEP et al (2017) Effects of supernatants from Escherichia coli Nissle 1917 and Faecalibacterium prausnitzii on intestinal epithelial cells and a rat model of 5-Fluorouracil-Induced Mucositis. Nutr Cancer 69:307\u2013318. https:\/\/doi.org\/10.1080\/01635581.2017.1263747","journal-title":"Nutr Cancer"},{"key":"10414_CR44","doi-asserted-by":"publisher","first-page":"5914","DOI":"10.1039\/D2FO00226D","volume":"13","author":"Z Zhao","year":"2022","unstructured":"Zhao Z, Xu S, Zhang W et al (2022) Probiotic Escherichia coli NISSLE 1917 for inflammatory bowel disease applications. Food Funct 13:5914\u20135924. https:\/\/doi.org\/10.1039\/D2FO00226D","journal-title":"Food Funct"},{"key":"10414_CR45","doi-asserted-by":"publisher","first-page":"e1308","DOI":"10.1371\/journal.pone.0001308","volume":"2","author":"SN Ukena","year":"2007","unstructured":"Ukena SN, Singh A, Dringenberg U et al (2007) Probiotic Escherichia coli Nissle 1917 inhibits leaky gut by enhancing Mucosal Integrity. PLoS ONE 2:e1308. https:\/\/doi.org\/10.1371\/journal.pone.0001308","journal-title":"PLoS ONE"},{"key":"10414_CR46","doi-asserted-by":"publisher","first-page":"e13388","DOI":"10.1111\/nmo.13388","volume":"30","author":"MR Barbaro","year":"2018","unstructured":"Barbaro MR, Fuschi D, Cremon C et al (2018) Escherichia coli Nissle 1917 restores epithelial permeability alterations induced by irritable bowel syndrome mediators. Neurogastroenterol Motil 30:e13388. https:\/\/doi.org\/10.1111\/nmo.13388","journal-title":"Neurogastroenterol Motil"},{"key":"10414_CR47","doi-asserted-by":"publisher","unstructured":"Touchefeu Y, Montassier E, Nieman K et al (2014) Systematic review: the role of the gut microbiota in chemotherapy- or radiation-induced gastrointestinal mucositis - current evidence and potential clinical applications. Aliment Pharmacol Ther 40:409-21. https:\/\/doi.org\/10.1111\/apt.12878","DOI":"10.1111\/apt.12878"},{"key":"10414_CR48","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/nrc1318","volume":"4","author":"ST Sonis","year":"2004","unstructured":"Sonis ST (2004) The pathobiology of mucositis. Nat Rev Cancer 4:277\u2013284. https:\/\/doi.org\/10.1038\/nrc1318","journal-title":"Nat Rev Cancer"},{"key":"10414_CR49","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2018.8893","author":"S Kim","year":"2018","unstructured":"Kim S, Chun H, Choi H et al (2018) Ursodeoxycholic acid attenuates 5fluorouracilinduced mucositis in a rat model. Oncol Lett. https:\/\/doi.org\/10.3892\/ol.2018.8893","journal-title":"Oncol Lett"},{"key":"10414_CR50","first-page":"926","volume":"68","author":"J Jamali","year":"2018","unstructured":"Jamali J, Dayo A, Adeel A et al (2018) A survey on gastrointestinal adverse drug reactions of Doxorubicin and Cyclophosphamide combination therapy. J Pak Med Assoc 68:926\u2013928","journal-title":"J Pak Med Assoc"},{"key":"10414_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.jff.2018.12.027","author":"LCL De Jesus","year":"2019","unstructured":"De Jesus LCL, Drumond MM, de Carvalho A et al (2019) Protective effect of Lactobacillus delbrueckii subsp. Lactis CIDCA 133 in a model of 5 Fluorouracil-Induced intestinal mucositis. J Funct Foods. https:\/\/doi.org\/10.1016\/j.jff.2018.12.027","journal-title":"J Funct Foods"},{"key":"10414_CR52","doi-asserted-by":"publisher","first-page":"858036","DOI":"10.3389\/fmicb.2022.858036","volume":"13","author":"FAL Barroso","year":"2022","unstructured":"Barroso FAL, de Jesus LCL, da Silva TF et al (2022) Lactobacillus delbrueckii CIDCA 133 ameliorates Chemotherapy-Induced Mucositis by modulating epithelial barrier and TLR2\/4\/Myd88\/NF-\u03baB signaling pathway. Front Microbiol 13:858036. https:\/\/doi.org\/10.3389\/fmicb.2022.858036","journal-title":"Front Microbiol"},{"key":"10414_CR53","doi-asserted-by":"publisher","first-page":"671","DOI":"10.4161\/cbt.11.7.14896","volume":"11","author":"LD Prisciandaro","year":"2011","unstructured":"Prisciandaro LD, Geier MS, Butler RN et al (2011) Probiotic factors partially improve parameters of 5-fluorouracil-induced intestinal mucositis in rats. Cancer Biol Ther 11:671\u2013677. https:\/\/doi.org\/10.4161\/cbt.11.7.14896","journal-title":"Cancer Biol Ther"},{"key":"10414_CR54","doi-asserted-by":"publisher","DOI":"10.1111\/lam.12741","author":"NS Oh","year":"2017","unstructured":"Oh NS, Lee JMY, Lee JMY et al (2017) Mulberry leaf extract fermented with Lactobacillus acidophilus A4 ameliorates 5-fluorouracil-induced intestinal mucositis in rats. Lett Appl Microbiol. https:\/\/doi.org\/10.1111\/lam.12741","journal-title":"Lett Appl Microbiol"},{"key":"10414_CR55","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1186\/s12866-019-1534-3","volume":"19","author":"C-S Alvarez","year":"2019","unstructured":"Alvarez C-S, Gim\u00e9nez R, Ca\u00f1as M-A et al (2019) Extracellular vesicles and soluble factors secreted by Escherichia coli Nissle 1917 and ECOR63 protect against enteropathogenic E. Coli-induced intestinal epithelial barrier dysfunction. BMC Microbiol 19:166. https:\/\/doi.org\/10.1186\/s12866-019-1534-3","journal-title":"BMC Microbiol"},{"key":"10414_CR56","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1007\/s00441-017-2785-7","volume":"371","author":"J Wang","year":"2018","unstructured":"Wang J (2018) Neutrophils in tissue injury and repair. Cell Tissue Res 371:531\u2013539. https:\/\/doi.org\/10.1007\/s00441-017-2785-7","journal-title":"Cell Tissue Res"},{"key":"10414_CR57","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1053\/j.gastro.2020.06.038","volume":"159","author":"M Rawat","year":"2020","unstructured":"Rawat M, Nighot M, Al-Sadi R et al (2020) IL1B increases intestinal tight junction permeability by Up-regulation of MIR200C-3p, which degrades occludin mRNA. Gastroenterology 159:1375\u20131389. https:\/\/doi.org\/10.1053\/j.gastro.2020.06.038","journal-title":"Gastroenterology"},{"key":"10414_CR58","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1002\/ibd.20339","volume":"14","author":"J Seiderer","year":"2008","unstructured":"Seiderer J, Elben I, Diegelmann J et al (2008) Role of the novel Th17 cytokine IL-17F in inflammatory bowel disease (IBD): upregulated colonic IL-17F expression in active Crohn\u02bcs disease and analysis of the IL17F p.His161Arg polymorphism in IBD. Inflamm Bowel Dis 14:437\u2013445. https:\/\/doi.org\/10.1002\/ibd.20339","journal-title":"Inflamm Bowel Dis"},{"key":"10414_CR59","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/ni.1736","volume":"10","author":"W O\u2019Connor Jr","year":"2009","unstructured":"O\u2019Connor W Jr, Kamanaka M, Booth CJ et al (2009) A protective function for interleukin 17A in T cell\u2013mediated intestinal inflammation. Nat Immunol 10:603\u2013609. https:\/\/doi.org\/10.1038\/ni.1736","journal-title":"Nat Immunol"},{"key":"10414_CR60","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.1002\/ibd.21248","volume":"16","author":"M Sarra","year":"2010","unstructured":"Sarra M, Pallone F, MacDonald TT, Monteleone G (2010) IL-23\/IL-17 axis in IBD. Inflamm Bowel Dis 16:1808\u20131813. https:\/\/doi.org\/10.1002\/ibd.21248","journal-title":"Inflamm Bowel Dis"},{"key":"10414_CR61","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1053\/j.gastro.2008.10.018","volume":"136","author":"M Leppkes","year":"2009","unstructured":"Leppkes M, Becker C, Ivanov II et al (2009) ROR\u03b3-Expressing Th17 cells induce murine chronic intestinal inflammation via redundant effects of IL-17A and IL-17F. Gastroenterology 136:257\u2013267. https:\/\/doi.org\/10.1053\/j.gastro.2008.10.018","journal-title":"Gastroenterology"},{"key":"10414_CR62","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.immuni.2008.03.004","volume":"28","author":"W Ouyang","year":"2008","unstructured":"Ouyang W, Kolls JK, Zheng Y (2008) The biological functions of T helper 17 cell effector cytokines in inflammation. Immunity 28:454\u2013467. https:\/\/doi.org\/10.1016\/j.immuni.2008.03.004","journal-title":"Immunity"},{"key":"10414_CR63","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/1477-5751-13-6","volume":"13","author":"TU Maioli","year":"2014","unstructured":"Maioli TU, de Melo Silva B, Dias MN et al (2014) Pretreatment with Saccharomyces boulardii does not prevent the experimental mucositis in Swiss mice. J Negat Results Biomed 13:6. https:\/\/doi.org\/10.1186\/1477-5751-13-6","journal-title":"J Negat Results Biomed"},{"key":"10414_CR64","doi-asserted-by":"publisher","first-page":"S49","DOI":"10.1093\/advances\/nmy063","volume":"10","author":"J Plaza-Diaz","year":"2019","unstructured":"Plaza-Diaz J, Ruiz-Ojeda FJ, Gil-Campos M, Gil A (2019) Mechanisms of action of probiotics. Adv Nutr 10:S49\u2013S66. https:\/\/doi.org\/10.1093\/advances\/nmy063","journal-title":"Adv Nutr"},{"key":"10414_CR65","doi-asserted-by":"publisher","first-page":"e31808","DOI":"10.1371\/journal.pone.0031808","volume":"7","author":"C-T Chang","year":"2012","unstructured":"Chang C-T, Ho T-Y, Lin H et al (2012) 5-Fluorouracil induced intestinal mucositis via nuclear factor-\u03baB activation by transcriptomic analysis and in vivo bioluminescence imaging. PLoS ONE 7:e31808","journal-title":"PLoS ONE"},{"key":"10414_CR66","doi-asserted-by":"publisher","unstructured":"Yeung CY, Chan WT, Jiang C, Bin et al (2015) Amelioration of chemotherapy-induced intestinal mucositis by orally administered probiotics in a mouse model. PLoS ONE. https:\/\/doi.org\/10.1371\/journal.pone.0138746","DOI":"10.1371\/journal.pone.0138746"},{"key":"10414_CR67","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2021\/9321196","volume":"2021","author":"Y Wu","year":"2021","unstructured":"Wu Y, Wu J, Lin Z et al (2021) Administration of a probiotic mixture ameliorates cisplatin-induced mucositis and Pica by regulating 5-HT in rats. J Immunol Res 2021:1\u201316. https:\/\/doi.org\/10.1155\/2021\/9321196","journal-title":"J Immunol Res"},{"key":"10414_CR68","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-024-08135-z","author":"M Jans","year":"2024","unstructured":"Jans M, Kolata M, Blancke G et al (2024) Colibactin-driven colon cancer requires adhesin-mediated epithelial binding. Nature. https:\/\/doi.org\/10.1038\/s41586-024-08135-z","journal-title":"Nature"}],"container-title":["Probiotics and Antimicrobial Proteins"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12602-024-10414-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12602-024-10414-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12602-024-10414-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T12:44:05Z","timestamp":1763642645000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12602-024-10414-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,26]]},"references-count":68,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["10414"],"URL":"https:\/\/doi.org\/10.1007\/s12602-024-10414-0","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3592871\/v1","asserted-by":"object"}]},"ISSN":["1867-1306","1867-1314"],"issn-type":[{"value":"1867-1306","type":"print"},{"value":"1867-1314","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,26]]},"assertion":[{"value":"20 November 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The experiment was conducted with the Brazilian College of Animal Experimentation (COBEA) and approved by the \u201cUse of Animals Ethics Committee\u201d from UFMG (CEUA\u2014UFMG) under protocol 210\/2022.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}